| Followers | 37 |
| Posts | 15270 |
| Boards Moderated | 0 |
| Alias Born | 08/29/2012 |
Wednesday, May 20, 2026 1:10:24 PM
Let's be honest...
If a buyout was going to happen it would have already happened -- It's been 10+ months.
Nasrat even ADMITTED all the offers were on the table OVER 3 MONTHS AGO and that they would QUOTE "evaluate each opportunity" -- AS IF they hadn't already done that Lol
He even ADMITTED that every company offered their QUOTE "lowest price possible".
He also ADMITTED there was QUOTE "No letters of intent".
And it's COMMON SENSE why as I have explained MULTIPLE times:
❌️ 1. You CANNOT sell Elite with The Mikah Scam attached
❌️ 2. You CANNOT sell Elite while on the OTC
The BEST we can hope for at this point is some sort of LOW-LEVEL merger followed by uplisting.
Thanks.
If a buyout was going to happen it would have already happened -- It's been 10+ months.
Nasrat even ADMITTED all the offers were on the table OVER 3 MONTHS AGO and that they would QUOTE "evaluate each opportunity" -- AS IF they hadn't already done that Lol
He even ADMITTED that every company offered their QUOTE "lowest price possible".
He also ADMITTED there was QUOTE "No letters of intent".
And it's COMMON SENSE why as I have explained MULTIPLE times:
❌️ 1. You CANNOT sell Elite with The Mikah Scam attached
❌️ 2. You CANNOT sell Elite while on the OTC
The BEST we can hope for at this point is some sort of LOW-LEVEL merger followed by uplisting.
Thanks.
Let the negotiations proceed.
MAKE ELITE GREAT AGAIN!
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/01/2026 11:00:24 AM
- Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product • Newsfile • 06/01/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
